scholarly journals The Role of Antiplatelet agents in ischemic events

2021 ◽  
Vol 11 (4-S) ◽  
pp. 187-194
Author(s):  
Sara Shreen ◽  
Mohammed Baleeqh Uddin ◽  
Mir Salman Ali ◽  
Zoha Sultana

Antiplatelet treatment could be a key in pharmacological treatment for avoidance of coronary heart disease (CHD) and stroke. Depending on sign, term of antiplatelet monotherapy or double treatment is shifted. Antiplatelet treatment is shown to avoid a repeat of cardiovascular occasion, in any case, expanded term of dual antiplatelet treatment (DAPT) related with expanded hazard of bleeding. Unstable angina happens due to partially or totally block of the blood coronary blood vessel driving to coronary ischaemia. Intense coronary infection happens due to drawn out coronary ischaemia which causes coronary diseases. Keywords: dual antiplatelet treatment (DAPT), coronary heart disease (CHD) and stroke.

2020 ◽  
Vol 7 (1) ◽  
pp. 99
Author(s):  
Ike Dhiah Rochmawati ◽  
Zakiah Rizka Rachmadania Arifin

ABSTRACT Antiplatelet is the most commonly drug used as secondary prevention for Coronary Heart Disease (CHD). The aim of this study was to determine the profile of the use of antiplatelet related with its efficacy and side effects. Observational methods with cross sectional approach for 3 months follow up was used,  a descriptive analysis carried out at the private hospital in Surabaya.  Results from this study: aspirin 80 mg was the most prescribed antiplatelet in patients with the incidence of ischemic events 9%. Higher ischemic events also seen in patients with hypertension, dyslipidemia, and Diabetes Mellitus. Bleeding and gastrointestinal disturbance as side effects occurred in 4 patients who used aspirin as antiplatelet, and based for Naranjo scale can be concluded as possible adverse drug reaction.  Keywords: Coronary Heart Disease, Antiplatelet , Ischemic events, Bleeding 


2018 ◽  
Vol 2 (1) ◽  
pp. 47-54
Author(s):  
Eleonora TASHKENBAEVA ◽  
◽  
Dilshod TOGAEV ◽  
Farzona KADIROVA ◽  
Shukhrat ZIYADULLAEV ◽  
...  

Author(s):  
Jeini Ester Nelwan ◽  
Edi Widjajanto ◽  
Sri Andarini ◽  
Sasmito Djati ◽  
Oksfriani Jufri Sumampouw

2002 ◽  
Vol 4 (6) ◽  
pp. 414-418 ◽  
Author(s):  
Michael Miller ◽  
Barbara Cosgrove ◽  
Stephen Havas

Sign in / Sign up

Export Citation Format

Share Document